IL1R1 and cystic fibrosis: In the present study, we determine the relative contribution of different inflammasomes to infection and inflammation in CF mice, assessed the therapeutic efficacy of the recombinant IL-1R antagonist (IL-1Ra), anakinra, and evaluated whether genetic variations in the inflammasome/IL-1RI signalling could contribute to microbial colonization and inflammation in human CF.